OSLO, Norway, Oct. 10, 2024 /PRNewswire/ — Oncoinvent, a clinical stage, radiopharmaceutical company developing innovative treatments for solid cancers, today announced that the first patient has been dosed in its Phase 2 study of Radspherin® […]
Tag: Biotechnology
Conference call interim report
GOTHENBURG, Sweden, Oct. 10, 2024 /PRNewswire/ — Invitation to attend Vitrolife AB (publ) conference call regarding presentation of the interim report Q3, 2024. The presentation will be held in English. Time: Thursday 24 October, 2024 […]
Astellas to Present VEOZA™ (fezolinetant) Data at IMS World Congress on Menopause
TOKYO, Oct. 10, 2024 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) announced that VEOZA™ (fezolinetant)*, its first-in-class treatment for moderate to severe vasomotor symptoms (VMS) associated with menopause, will be featured […]
Harbour BioMed Announces Publication of the Phase I Study Results for Porustobart in Combination with Toripalimab in Advanced Melanoma and Other Solid Tumors
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Oct. 9, 2024 /PRNewswire/ — Harbour BioMed (the “Company”; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology […]
CZI, State and City Leaders Launch Chan Zuckerberg Biohub New York
CZ Biohub New York is catalyzing collaboration among scientists in the New York area from Columbia University, The Rockefeller University, and Yale University. NEW YORK, Oct. 9, 2024 /PRNewswire/ — Today, leadership from Chan Zuckerberg Biohub […]